|
During the second quarter of 2022, one of the
nine-month notes was extended for an additional 60 days, until August 1, 2022. As consideration for the 60-day extension, the Company
agreed to pay 100,000 shares of common stock to the note holder, reduce the conversion price of the note, and reprice the associated warrants
from $3.00 per share to $1.00 per share. The new conversion price shall be equal to the lower of (i) 50% of the lowest volume weighted
average prices for common stock as reported at the close of trading on the market reporting trade prices for the common stock during the
30 trading days ending on, and including, the date of the notice of conversion and (ii) Closing Price on the Closing Date, not to exceed
$2.25. On July 13, 2022, one of the notes was extended to September 1, 2022 in exchange for 183,780 warrants to purchase common stock
at $3.00 per share, 75,512 shares of common stock and the principal amount of the note was increased by $70,833. On September 8, 2022,
the note was further extended to May 26, 2023 and the interest rate increased from 10% to 18% per annum. The Company recognized $252,429
loss on extinguishment from the amendment of the note. On August 18, 2022, another note was further extended to September 30, 2022, in
exchange for 200,000 shares of common stock. During the fourth quarter of 2022, the note was extended until May 31, 2023.
During the third and fourth quarters of 2022,
the Company issued an aggregate of $400,000 of convertible notes payable net of discount, in various tranches. The notes accrue interest
ranging between 10% and prime plus 8% per annum and mature nine months from the date of each issuance. In addition, the lenders received
95,115 warrants with an exercise price of the lowest of $2.685 or 65% of lowest traded price in preceding 30 days and 81,760 warrants
with an exercise price of lowest of $2.685 or 50% of VWAP for the preceding 30 days, with all warrants having an expiry of 5 years from
the date of issuance.
During the year ended December 31, 2022, $798,526
of principal and $25,473 of accrued interest was converted into 4,114,816 common shares leaving a balance, net of discount, of $482,885
and accrued interest of $381,259 as of December 31, 2022.
On February 28, 2023, the Company entered
into a Global Settlement and Exchange of Senior Secured Convertible Promissory Note with Leonite Fund 1, LP (“Leonite), whereby
Leonite agreed to settle all of its outstanding liability and the cancellation of their warrants in exchange for 10,538,152
common stock of the Company and 110,000
warrants to purchase common stock of the Company at $0.05 per share. The agreement is contingent upon all other holders executing
agreements to convert their balances.
On March 27, 2023, the Company and an
institutional investor (the “Holder”) executed an investment agreement for up to $7,000,000
through a convertible promissory note, share purchase agreement and warrant agreement (the “2023 Note"). The 2023 Note has
a principal amount of up to $7,000,000
with an original issue discount of 12%
and is to be disbursed in four (4) disbursements as set forth as follows: (i)
the first disbursement in the amount of $1,000,000 occurred on March 27, 2023; (ii) the second disbursement in the amount of
$200,000 is due within three (3) days after the filing of an S-1 registration statement; (iii) the third disbursement in the amount
of $500,000 is due forty-five (45) days after effectiveness of an S-1 registration statement; and (iv) $120,000 is due forty-five
(45) days after the third disbursement. The S-1 Registration Statement was filed on May 9, 2023. The 2023 Note carries an
interest rate equal to seven percent (7%) per annum and is redeemable by the Company at any time at an amount equal to one hundred
twenty-five percent (125%) of the then outstanding principal and interest accrued on the Note. All additional disbursements will be
made at the Holder’s discretion, at any time, and if the Holder’s broker refuses to custody the securities issued in
connection therewith, the Holder will have no obligation to make a disbursement under the disbursement schedule but will have the
option to make such disbursement.
On April 11, 2023, the Company entered into an
Amendment of Promissory Note with MCUS LLC (“MCUS”), whereby MCUS agreed to convert its conversion price to $0.05.
The balance of the four convertible notes payable,
net of discount, as of March 31, 2023 and December 31, 2022 was $739,315 and $482,885, respectively. |